Structure based virtual screening, docking and molecular dynamic simulation studies to identify potent MDM2-P53 interaction inhibitors for cancer therapy
Design synthesis and pharmacological evaluation of 2 5 disubstituted 1 3 4 oxadiazole glycine alanine hybrids as class i histone deacetylase inhibitors
